Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.
about
Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overviewThe role of inflammation in cancer of the esophagus.Barrett's oesophagus: Current controversies.Adjuvant Statin Therapy for Esophageal Adenocarcinoma: A Cost-Utility Analysis.
P2860
Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Statins and aspirin for chemop ...... a cost-effectiveness analysis.
@en
Statins and aspirin for chemop ...... a cost-effectiveness analysis.
@nl
type
label
Statins and aspirin for chemop ...... a cost-effectiveness analysis.
@en
Statins and aspirin for chemop ...... a cost-effectiveness analysis.
@nl
prefLabel
Statins and aspirin for chemop ...... a cost-effectiveness analysis.
@en
Statins and aspirin for chemop ...... a cost-effectiveness analysis.
@nl
P2093
P2860
P1476
Statins and aspirin for chemop ...... a cost-effectiveness analysis
@en
P2093
Angela C Tramontano
Chung Yin Kong
Katherine E Perzan
Sung Eun Choi
P2860
P304
P356
10.1158/1940-6207.CAPR-13-0191-T
P50
P577
2013-12-31T00:00:00Z